SARS-CoV-2 Related Kit Products

Anti-SARS-CoV-2 (B.1.1.7) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD) (Cat.No.RAS-N028) is used to detect the inhibition of SARS-CoV-2 RBD/human ACE2 interaction by anti-SARS-CoV-2 neutralizing antibodies Cat. No. S1N-M122, Cat. No. SPD-M128 and Cat. No. SPD-M180. As shown in the figure above, Cat. No. S1N-M122 is more potent than Cat. No. SPD-M128 and Cat. No. SPD-M180 in blocking SARS-CoV-2 RBD/human ACE2 interaction.

Anti-SARS-CoV-2 (B.1.351) Neutralizing Antibody Titer Serologic Assay Kit (Spike RBD) (Cat.No.RAS-N031) is used to detect the inhibition of SARS-CoV-2 RBD/human ACE2 interaction by anti-SARS-CoV-2 neutralizing antibodies Cat. No. S1N-M122, Cat. No. SPD-M128 and Cat. No. SPD-M180. As shown in the figure above, Cat. No. S1N-M122 is more potent than Cat. No. SPD-M128 and Cat. No. SPD-M180 in blocking SARS-CoV-2 RBD/human ACE2 interaction.

Detection of Monoclonal Anti-SARS-CoV-2 Antibody, Human IgG1 titer by Indirect-ELISA Assay Immobilized SARS-CoV-2 Spike RBD at 0.2 μg/mL (100 μL/well) can bind Monoclonal Anti-SARS-CoV-2 Antibody, Human IgG1 in 1:50 human serum. Detection was performed using HRP-Conjugated Anti-human IgG antibody with sensitivity of 24 ng/mL.

Detection of Anti-SARS-CoV-2 Antibody, Human IgG1 titer by Indirect-ELISA Assay. Immobilized SARS-CoV-2 Spike Protein at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-SARS-CoV-2 Antibody, Human IgG1 in 1:50 human serum. Detection was performed using HRP-Conjugated Anti-human IgG antibody with sensitivity of 12 ng/mL